Neogen Return On Capital Employed from 2010 to 2024

NEOG Stock  USD 14.14  0.03  0.21%   
Neogen's Return On Capital Employed is decreasing over the last several years with very volatile swings. Return On Capital Employed is predicted to flatten to 0.01. During the period from 2010 to 2024 Neogen Return On Capital Employed regressed destribution of quarterly values had mean deviationof  0.07 and mean square error of  0.01. View All Fundamentals
 
Return On Capital Employed  
First Reported
2010-12-31
Previous Quarter
0.01334916
Current Value
0.0127
Quarterly Volatility
0.10789841
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Neogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 127.3 M, Interest Expense of 77.1 M or Total Revenue of 970.4 M, as well as many indicators such as Price To Sales Ratio of 3.17, Dividend Yield of 0.0 or PTB Ratio of 0.86. Neogen financial statements analysis is a perfect complement when working with Neogen Valuation or Volatility modules.
  
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

Latest Neogen's Return On Capital Employed Growth Pattern

Below is the plot of the Return On Capital Employed of Neogen over the last few years. It is Neogen's Return On Capital Employed historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neogen's overall financial position and show how it may be relating to other accounts over time.
Return On Capital Employed10 Years Trend
Very volatile
   Return On Capital Employed   
       Timeline  

Neogen Return On Capital Employed Regression Statistics

Arithmetic Mean0.06
Coefficient Of Variation168.11
Mean Deviation0.07
Median0.08
Standard Deviation0.11
Sample Variance0.01
Range0.4258
R-Value(0.05)
Mean Square Error0.01
R-Squared0
Significance0.87
Slope(0)
Total Sum of Squares0.16

Neogen Return On Capital Employed History

2024 0.0127
2023 0.0133
2022 0.008509
2021 0.0382
2020 0.0613
2019 0.0656
2018 0.0768

About Neogen Financial Statements

Neogen stakeholders use historical fundamental indicators, such as Neogen's Return On Capital Employed, to determine how well the company is positioned to perform in the future. Although Neogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neogen's assets and liabilities are reflected in the revenues and expenses on Neogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neogen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Capital Employed 0.01  0.01 

Currently Active Assets on Macroaxis

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.86)
Earnings Share
(0.11)
Revenue Per Share
4.212
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0085
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.